Literature DB >> 17055435

Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.

Yongna Xing1, Yanhui Xu, Yu Chen, Philip D Jeffrey, Yang Chao, Zheng Lin, Zhu Li, Stefan Strack, Jeffry B Stock, Yigong Shi.   

Abstract

The serine/threonine phosphatase protein phosphatase 2A (PP2A) plays an essential role in many aspects of cellular functions and has been shown to be an important tumor suppressor. The core enzyme of PP2A comprises a 65 kDa scaffolding subunit and a 36 kDa catalytic subunit. Here we report the crystal structures of the PP2A core enzyme bound to two of its inhibitors, the tumor-inducing agents okadaic acid and microcystin-LR, at 2.6 and 2.8 A resolution, respectively. The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15. Formation of the core enzyme forces the scaffolding subunit to undergo pronounced structural rearrangement. The scaffolding subunit exhibits considerable conformational flexibility, which is proposed to play an essential role in PP2A function. These structures, together with biochemical analyses, reveal significant insights into PP2A function and serve as a framework for deciphering the diverse roles of PP2A in cellular physiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055435     DOI: 10.1016/j.cell.2006.09.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  108 in total

1.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

Review 2.  Structural basis for protein phosphatase 1 regulation and specificity.

Authors:  Wolfgang Peti; Angus C Nairn; Rebecca Page
Journal:  FEBS J       Date:  2012-02-24       Impact factor: 5.542

3.  PP2A regulates the pro-apoptotic activity of FOXO1.

Authors:  Ling Yan; Viviana A Lavin; Leta R Moser; Qinghua Cui; Cindy Kanies; Elizabeth Yang
Journal:  J Biol Chem       Date:  2008-01-21       Impact factor: 5.157

4.  Bioinformatic identification of novel protein phosphatases in the dog genome.

Authors:  Mrigendra B Karmacharya; Jae-Won Soh
Journal:  Mol Cell Biochem       Date:  2011-01-15       Impact factor: 3.396

5.  Deprotonation states of the two active site water molecules regulate the binding of protein phosphatase 5 with its substrate: A molecular dynamics study.

Authors:  Lingyun Wang; Feng Yan
Journal:  Protein Sci       Date:  2017-07-28       Impact factor: 6.725

6.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

7.  A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells.

Authors:  Karl Staser; Matthew A Shew; Elizabeth G Michels; Muithi M Mwanthi; Feng-Chun Yang; D Wade Clapp; Su-Jung Park
Journal:  Exp Hematol       Date:  2012-10-11       Impact factor: 3.084

8.  Transcriptional regulation of PP2A-A alpha is mediated by multiple factors including AP-2alpha, CREB, ETS-1, and SP-1.

Authors:  He-Ge Chen; Wen-Jun Han; Mi Deng; Jichao Qin; Dan Yuan; Jin-Ping Liu; Ling Xiao; Lili Gong; Songping Liang; Jian Zhang; Yun Liu; David Wan-Cheng Li
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

Review 9.  Molecular mechanisms of microcystin toxicity in animal cells.

Authors:  Alexandre Campos; Vitor Vasconcelos
Journal:  Int J Mol Sci       Date:  2010-01-21       Impact factor: 6.208

Review 10.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.